Literature DB >> 7040771

Isolation, culture, and transplantation of human hepatocytes.

S C Strom, R L Jirtle, R S Jones, D L Novicki, M R Rosenberg, A Novotny, G Irons, J R McLain, G Michalopoulos.   

Abstract

The in situ two-step collagenase perfusion technique used for the isolation of hepatocytes from rat liver was adapted into a procedure applicable to pieces of human liver obtainable from surgical procedures. Human hepatocytes obtained by this method were maintained in primary culture for 10 days. The cellular changes observed at the light microscopic and electron microscopic levels are described. The changes in microsomal enzymes as a function of the age of the cultures were also measured. Exposure of the human hepatocytes to procarcinogens known to be metabolized by rodent liver resulted in unscheduled DNA synthesis. The isolated hepatocytes were also transplanted into two-thirds partially hepatectomized athymic nude mice. The transplanted cells formed nodules with characteristic hepatic architecture. These studies demonstrate that hepatocytes obtained from human liver by the described modified collagenase technique can be used for in vitro studies in chemical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040771

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  38 in total

1.  Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture.

Authors:  Jeanine L Page; Mary C Johnson; Katy M Olsavsky; Steven C Strom; Helmut Zarbl; Curtis J Omiecinski
Journal:  Toxicol Sci       Date:  2007-02-27       Impact factor: 4.849

2.  The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs.

Authors:  G Skibinski; A Skibinska; K James
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 3.  Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.

Authors:  George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

4.  Effects of epidermal growth factor on growth of cell lines established from cynomolgus monkey hepatocytes with SV40 T antigen.

Authors:  J P Condreay; L D Condreay; B E Huber
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-04       Impact factor: 2.416

5.  The disposition of SK&F L-94901, a selective thyromimetic in rat, dog and cynomolgus monkey.

Authors:  M A Pue; J A Ransley; D J Writer; A J Dean; E R Franklin; I G Beattie; D A Ross
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

6.  Human parenchymal and non-parenchymal liver cell isolation, culture and characterization.

Authors:  Georg Damm; Elisa Pfeiffer; Britta Burkhardt; Jan Vermehren; Andreas K Nüssler; Thomas S Weiss
Journal:  Hepatol Int       Date:  2013-10-10       Impact factor: 6.047

Review 7.  Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.

Authors:  Mustapha Najimi; Florence Defresne; Etienne M Sokal
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

8.  Enhancement of aldehyde dehydrogenase activity in human and rat hepatocyte cultures by 3-methylcholanthrene.

Authors:  M Marselos; S C Strom; G Michalopoulos
Journal:  Cell Biol Toxicol       Date:  1986-06       Impact factor: 6.691

9.  Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens.

Authors:  A M Pfeifer; K E Cole; D T Smoot; A Weston; J D Groopman; P G Shields; J M Vignaud; M Juillerat; M M Lipsky; B F Trump
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Decreased number of asialoglycoprotein receptors in diabetic BB Wistar rat.

Authors:  P Scarmato; C Cherqui-Eisenberg; G Durand; J Feger
Journal:  Experientia       Date:  1989-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.